How much funding has Curebase raised?

Curebase has raised $55.0M in total funding, most recently a Series B round.

Who are Curebase's investors?

Curebase's investors include Industry Ventures, GGV Capital, Acrew Capital, World Innovation Lab, Positive Sum, Gaingels.

Where is Curebase headquartered?

Curebase is headquartered in San Francisco, California, United States.

What industry is Curebase in?

Curebase operates in Healthcare.

Curebase

Modern, AI-powered clinical trial software platform.

San Francisco, United States · Founded 2017 · $55.0M raised

Healthcare

YC S18

Headquarters: San Francisco, California
Employees: 51–200
Founded: 2017
Business Model: B2B

Website: curebase.com
Total Funding: $55.0M
Last Round: $40.0M Series BMay 2022
Rounds: 2

About

Curebase is the modern eClinical platform built for flexibility, usability, and full-study oversight. We empower sponsors, CROs, and sites to launch studies faster, deliver better participant experiences, and seamlessly capture data with next-gen, AI-powered ePRO, eConsent, engagement tools, and integrated EDC.

Summary

Curebase is a Healthcare company based in San Francisco, United States, founded in 2017. It has raised $55.0M in total across 2 rounds, most recently a $40.0M Series B round in May 2022. Investors include Industry Ventures, GGV Capital and Acrew Capital.

LinkedIn X (Twitter)GitHub